GCP-Service International Limited & Co. KG
GCP-Service International Limited & Co. KG is recorded as a service provider in 11 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 11 of 11 trials · Latest update first
A phase II study evaluating the efficacy and safety of imetelstat in patients with HR myelodysplastic syndromes or AML failing HMA-based therapy
Sponsor Gcp-Service International West GmbH
- Start (EU)
- Latest update
- Estimated end
Operational learnings available3 trial-level findings · Read insights
- The interim analysis of the first 21 evaluable patients identified no primary-endpoint responders; the dosing schedule was amended and subsequent efficacy analyses continued exploratorily.
- High early discontinuation and death rates resulted in limited evaluable efficacy data, and substantial missing data added uncertainty to the results.
- Delayed serious-adverse-event reporting occurred because several sites were uncertain whether progression to AML met serious-adverse-event reporting criteria.
These findings describe the trial, not the service provider’s performance or responsibility.
A phase II, open-label, multicenter study of orally administered RVU120 for the treatment of anemia in patients with lower-risk myelodysplastic neoplasms (MDS)
Sponsor GCP-Service International West GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Peripheral Edema Resolution evaluated in patients switched from amlodipine to Levamlodipine (PERLA)
Sponsor Zentiva k.s.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Multi-Center, Randomized, Single-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral TTI-0102 for Treatment of Patients with Mitochondrial encephalomyopathy, lactic acidosis and strokelike episodes (MELAS).
Sponsor Thiogenesis Therapeutics
- Start (EU)
- Latest update
- Estimated end
- Not reported
Antioxidant Treatment with Vitamin C in Cardiac Surgery Patients – A Pilot Randomized Controlled Trial
Sponsor GCP-Service International West GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase II study of standard of care therapy azacitidine (AZA) combined with venetoclax (VEN) and Tagraxofusp (TAG) in patients with higher-Risk chronic myelomonocytic Leukemia (CMML): the PATROL Study
Sponsor GCP-Service International West GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two-arm, Double Blind Study to Assess Efficacy and Safety of D-PLEX Administered Concomitantly with the Standard of Care (SoC), Compared to a SoC Treated Control Arm, in Prevention of Post Abdominal Surgery Incisional Infection.
Sponsor Polypid Ltd.
- Start (EU)
- Latest update
- Estimated end
VItamin C in Thermal injuRY: The VICToRY Trial A phase III multi-center randomized trial
Sponsor Queen's University
- Start (EU)
- Latest update
- Estimated end
Intravenous Fish Oil based Lipid Emulsion to enhance recovery in High-Risk Cardiac Surgery Patients: a phase II multicenter trial
Sponsor Gcp-Service International West GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Effects of Dopaminergic Therapy in Patients with Alzheimer's Disease: A 24 weeks prospective, randomized, double-blind, placebo-controlled, parallel group, international, multi-center phase III study evaluating efficacy and safety of rotigotine 4mg/24 hrs in combination with rivastigmine 9.5 mg/24 hrs in mild to moderate Alzheimer's disease patients.
Sponsor Fondazione Santa Lucia IRCCS
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized, double-blind, single-center, 2-period cross-over Phase I study to assess the tolerability, safety and pharmacokinetics of antidepressant doses of oral ketamine hydrochloride prolonged release tablets (KET01) compared to intranasal esketamine in healthy male subjects
Sponsor Ketabon GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for GCP-Service International Limited & Co. KG?
The 2026-10-09 snapshot links GCP-Service International Limited & Co. KG to 11 distinct CTIS trials. Recorded services include Regulatory services, Clinical monitoring, Project management, Statistical analysis, among 14 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for GCP-Service International Limited & Co. KG?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to GCP-Service International Limited & Co. KG conducted?
The linked trials record locations in 12 countries, including Germany, Italy, France, Spain, Czechia. These are trial locations, not confirmed office locations or countries where GCP-Service International Limited & Co. KG delivered services.
What can this page tell me about GCP-Service International Limited & Co. KG's trial experience?
Browse 11 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under GCP-Service International Limited & Co. KG. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- GCP-Service International Limited & Co. KG